On October 20, UnitedHealth rose 3.14% in Regular Trading, trading at $419.62/share, with turnover of $956 million.
The clearest catalyst was an analyst action: RBC raised its price target on UnitedHealth to $498 from $478 while maintaining an Outperform rating, providing fresh support for sentiment toward the stock.
The rating change followed the company’s stronger third-quarter update released on October 13, when UnitedHealth reported adjusted EPS of $4.69 on revenue of $112.69 billion, both above consensus, and lifted its full-year adjusted EPS outlook to at least $20.50 from $19.50 to $20. More recently, some firms trimmed targets after results, including Bernstein lowering its target to $500 from $512, but RBC’s latest upward revision appears to be the most immediate driver behind the current move.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments